CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019
128
AFRICA
Forum
2016;
26
(3): 35–40.
63. Alpert BS, Quinn DE, Friedman BA. A review of the latest guidelines
for NIBP device validation.
Blood Press Monit
2013;
18
(6): 297–302.
64. Venet R, Miric D, Pavie A, Lacheheb D. Korotkoff sound: the cavitation
hypothesis.
Med Hypoth
2000;
55
(2): 141–146.
65. Cartwright FF. A short hstory of blood pressure measurement.
Proc R
Soc Med
1977;
70
(11): 793–799.
66. European Commission Scientific Committee on Emerging and Newly
Identified Health Risks (SCENIHR). Mercury sphygmomanom-
eters in healthcare and the feasibility of alternatives 2009; Available
from:
http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_025.pdf (assessed 5 May 2018).
67. Turner MJ, Speechly C, Bignell N. Sphygmomanometer calibration –
why, how and how often?
Aust Fam Physician
2007;
36
(10): 834–838.
68. National Institute for Health and Care Excellence. Hypertension in
adults: diagnosis and management (CG127), 2011.
69. American College of Cardiology/American Heart Association Task
Force on Clinical Practice Guidelines, 2017 ACC/AHA/AAPA/ABC/
ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the
Prevention, Detection, Evaluation, and Management of High Blood
Pressure in Adults: A Report of the American College of Cardiology/
American Heart Association Task Force on Clinical Practice Guidelines.
Available from:
http://www.onlinejacc.org/content/71/19/e127(accessed
26 July 2018).
70. Society of Obstetricians and Gynaecologists of Canada (SOGC).
Clinical practice guidelines. Diagnosis, evaluation, and management of
the hypertensive disorders of pregnancy: executive summary. No. 307.
J
Obstet Gynaecol Can
2014;
36
(5): 416–438.
71. Cloutier L, Daskalopoulou S, Padwal R, Lamarre-Cliche M, Bolli P,
McLean D,
et al
. A new algorithm for the diagnosis of hypertension in
Canada.
Can J Cardiol
2015;
31
(15): 620–630.
72. National Department of Health, Republic of South Africa. Guidelines
for maternity care in South Africa: A manual for clinics, commu-
nity health centres and district hospitals. 2015; Available from: https://
www.health-e.org.za/wp-content/uploads/2015/11/Maternal-Care-Guidelines-2015_FINAL-21.7.15.pdf (accessed 14 July 2018).
73. YK Seedat, Rayner B, Veriava Y, Hypertension guideline working group.
South African Hypertension Guideline 2014.
Cardiovasc J Afr
2014;
25
(6): 288–294.
74. Hartle A, McCormack T, Carlisle J, Anderson S, Pichel A, Beckett N,
et
al
. The measurement of adult blood pressure and management of hyper-
tension before elective surgery: Joint guidelines from the Association of
Anaesthetists of Great Britain and Ireland and the British Hypertension
Society.
Anaesthesia
2016;
71
(3): 326–327.
75. Nathan HL, Duhig K, Hezelgrave NL, Chappell LC, Shennan AH.
Blood pressure measurement in pregnancy.
Obstet Gynaecol
2015;
17
:
91–98.
76. Brown MA, Reiter L, Smith B, Buddle ML, Morris R, Whitworth JA.
Measuring blood pressure in pregnant women: a comparison of direct
and indirect methods.
Am J Obstet Gynecol
1994;
171
(3): 661–667.
77. American College of Obstetricans and Gynecologists (ACOG)
Committee on Obstetric Practice. Committee Opinion No. 692:
Emergent Therapy for Acute-Onset, Severe Hypertension During
Pregnancy and the Postpartum Period.
Obstet Gynaecol
2017;
129
(4):
e90–e95.
78. Berger A. Oscillatory Blood pressure monitoring devices.
Br Med J
2001;
323
(7318): 919.
79. Reay CA, Menses JA, Bousfield DR, Colechin ES, Sims AJ. Buyers’
guide. Hospital grade non-invasive blood pressure monitors, 2008.
Available from:
www.healthcheck.nhs.uk/document.php?o=10(assessed
19 July 2017).
80. De Greeff A, Beg Z, Gangji Z, Dorney E, Shennan AH. Accuracy of
inflationary versus deflationary oscillometry in pregnancy and preec-
lampsia: OMRON-MIT versus OMRON-M7.
Blood Press Monit
2009;
14
(1): 37–40.
81. Shennan AH, de Greeff A. Pre-eclampsia: etiology and clinical practice.
In: Lyall F, Belfort M, eds.
Measuring Blood Pressure in Pregnancy and
Pre-eclampsia
. United Kingdom: Cambridge University Press, 2007.
82. Chung Y, Brochut M, de Greeff A, Shennan A. Clinical accuracy of
inflationary oscillometry in pregnancy and pre-eclampsia: Omron-MIT
Elite.
Pregnancy Hypertens
2012;
2
: 411–415.
83. Nathan HL, de Greeff A, Hezelgrave NL, Chappell LC, Shennan AH.
Accuracy validation of the Microlife 3AS1-2 blood pressure device in a
pregnant population with low blood pressure.
Blood Press Monit
2015;
20
(5): 299–302.
84. Nathan HL, de Greeff A, Hezelgrave NL, Chappell LC, Shennan AH.
An accurate semiautomated oscillometric blood pressure device for use
in pregnancy (including pre-eclampsia) in a low-income and middle-
income country population: the Microlife 3AS1-2.
Blood Press Monit
2015;
20
(1): 52–55.
85. Chung Y, de Greeff A, Shennan A. Validation and compliance of
a home monitoring device in pregnancy: microlife WatchBP home.
Hypertens Pregnancy
2009;
28
(3): 348–359.
86. Topouchian J, Zelveian P, Asmar R. Validation of the automatic blood
pressure measurements device, the OMRON EVOLV (HEM- 7600
T-E)
®
in pregnancy according to the modified European Society of
Hypertension international protocol (ESH-IP). Available from: http://
www.dableducational.org/Publications/2017/ESH-IP%202010%20Validation%20of%20OMRON%20EVOLV%20(HEM-7600%20
T-E)%20v2.pdf (accessed 28 August 2018).
87. De Greeff A, Ghosh D, Anthony J, Shennan A. Accuracy assessment
of the Dinamap ProCare 400 in pregnancy and preeclampsia.
Hypertens
Pregnancy
2010;
29
(2): 198–205.
88. De Greeff A, Shennan AH. Clinical accuracy of a low-cost port-
able blood pressure device in pregnancy and pre-eclampsia: the Nissei
DS-400.
Trop Doct
2015;
45
(3): 168–173.
89. Bartosh LF, Dorogova JV, Kuznecova TN, Krylova AV. The testing of
BPLab ambulatory blood pressure monitor on the pregnant in conform-
ity with international protocol of the European Society of Hypertension
(ESH-2001).
Arterial Hypertens
2006;
12
: 3–6.
90. Dorogova IV, Panina ES. Comparison of the BPLab
®
sphygmomanom-
eter for ambulatory blood pressure monitoring with mercury sphyg-
momanometry in pregnant women: validation study according to the
British Hypertension Society protocol.
Vasc Health Risk Manage
2015;
11
: 245–249.
91. Penny JA, Shennan AH, Rushbrook J, Halligan AW, Taylor DJ, De
Sweit M. Validation of the Welch Allyn QuietTrak ambulatory blood
pressure monitor in pregnancy.
Hypertens Pregnancy
1996;
15
(3):
313–321.
92. Vischer AS, Burkard T. Principles of blood pressure measurement –
Current techniques, office vs ambulatory blood pressure measurement.
In: Islam S, ed.
Hypertension: From Basic Research to Clinical Practice.
Switzerland: Springer International Publishing AG; 2017: 85–96.
93. Chung E, Chen G, Alexander B, Cannesson M. Non-invasive continu-
ous blood pressure monitoring: a review of current applications.
Front
Med
2013;
7
(1): 91–101.
94. AnaesthesiaUK. Finapres. Available from:
http://www.frca.co.uk/article.aspx?articleid=100318 (assessed 21 July 2017).
95. Gupta D, Soskin V, Marjanovic M, Amhaz H, Mazumdar A. Continous
non-invasive arterial pressure device as an adjunct to recognize fluctuat-